Live Breaking News & Updates on Nitiation

Stay informed with the latest breaking news from Nitiation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nitiation and stay connected to the pulse of your community

EQS-News: Amoéba (ALMIB): Initiation of coverage - Fighting pathogens, respecting nature

EQS-News: / Key word(s): Research Update/Research Update Amoéba (ALMIB): Initiation of coverage - Fighting pathogens, respecting nature 15.03.2023 / 07:00 CET/CEST The issuer is

Germany , New-york , United-states , Athens , Attikír , Greece , Sydney , New-south-wales , Australia , United-kingdom , Tel-aviv , Israel

Verve Therapeutics Reports New Preclinical Data Demonstrating Potent and Durable Editing of ANGPTL3 Gene with VERVE-201 in Wild-type and LDLR-deficient Non-Human Primates

VERVE-201 Preclinical Data Supports Advancement of Drug Candidate Toward Clinical Development for Homozygous Familial Hypercholesterolemia, with Initiation of Clinical Trial Anticipated in 2024 Data... | March 3, 2023

Boston , Massachusetts , United-states , Jen-robinson , Andrew-bellinger , Exchange-commission , Editing-medicine-targeting , Clinical-development-for-homozygous-familial-hypercholesterolemia , Ernestn-morial-convention-center , Nasdaq , Verve-therapeutics-inc , Data-supports-advancement

Hexagon Composites ASA: Initiation of share buyback program to fulfil incentive programs obligations

2 March 2023: Hexagon Composite ASA has decided to initiate a buyback of up to 350,000 of its own shares for an amount up to NOK 20 million. The buyback program may be carried out in the period from this

Norway , Norwegian , Dennis-riedl , Ingrid-aarsnes , Linkedin , Twitter , Commission-delegated-regulation-eu-no , Hexagon-composite , Annual-general-meeting , Market-abuse-regulation , Commission-delegated-regulation , Hexagon-composites

Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants

-- Infant Phase 2 Study Initiation Expected in the Second Quarter of 2023, with Initial Topline Safety, Tolerability and Immunogenicity Data by 2025 -- -- Based on Positive Topline VAX-24 Phase 1/2... | February 21, 2023

United-states , Jim-wassil , Jennifer-zibuda , Janet-graesser , Groupa-strep , Drug-administration , Advisory-committee-on-immunization-practices , Nasdaq , Exchange-commission , Sutro-biopharma-inc , Corporate-communications , Initiation-of-pediatric-program-in-infants

Renexxion Ireland Limited: Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis

Randomized, double-blind, placebo-controlled study to evaluate efficacy of novel pan-GI prokinetic in patients with gastroparesis ROSCREA, Ireland and FREIBURG, Germany, Feb. 15, 2023 /PRNewswire/

Ireland , Italy , Germany , Australia , France , Switzerland , Roscrea , North-tipperary , Irish , Dennis-riedl , Falk-pharma , Peter-milner

AXMIN Inc. Confirms End of Mediation and Initiation of International Arbitration

Vancouver, British Columbia--(Newsfile Corp. - February 10, 2023) - AXMIN Inc. (TSXV: AXM) ("AXMIN" or the "Company") announces that the mediation process conducted with the government of the Central

Abidjan , Lagunes , Coted-ivoire , Central-african-republic , Canada , United-kingdom , Vancouver , British-columbia , British , Canadian , Lucy-yan , National-instrument

Enzolytics, Inc.: Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa

COLLEGE STATION, TX / ACCESSWIRE / February 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics, Inc. announced today the preliminary results of Toxicology studies of the Company's

Kenya , Rwanda , United-states , Texas , Botswana , America , American , Gaurav-chandra , Harry-zhabilov , Schwierige-zeiten , While-enzolytics-inc , Company-contact

Lakeland Industries, Inc.: Lakeland Industries Announces the Initiation of a Quarterly Dividend Program

HUNTSVILLE, AL / ACCESSWIRE / February 1, 2023 /Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing for industry, healthcare and

Mexico , Kazakhstan , United-states , India , Argentina , China , Ecuador , Uruguay , Chile , Colombia , Canada , Russia

MaaT Pharma Announces Initiation of Coverage of its Stock by Kepler Cheuvreux

Regulatory News: MaaT Pharma(EURONEXT: MAAT the "Company"), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival

France , French , Kepler-cheuvreuxtoday , Kepler-cheuvreux , Senior-pr-corporate-communications , Trophic-communications-corporate , Regulatory-news , Microbiome-ecosystem , Maat-pharma , Microbiome-ecosystem-therapies , Euronext-paris , Communications-manager

Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Initiation of Final Stage of Groundbreaking Opioid Overdose Protection Phase 1 Study

~ PF614-MPAR to be the Industry's First Overdose Protection Pain Product ~SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), (OTC PINK:ENSCW)

Miami , Florida , United-states , Lynn-kirkpatrick , Ensysce-biosciences , Shannon-devine , Ensysce-biosciences-inc-view , Ensysce-biosciences-inc , Quotient-sciences , Mz-group-north-america , Ensysce-biosciences-company-contact , First-overdose-protection-pain-product